Navigation Links
EntreMed Presents Results for ENMD-1198 and Vincristine in Preclinical Leukemia Models
Date:12/10/2007

Prolonged Survival in Leukemia Models Demonstrated

ROCKVILLE, Md., Dec. 10 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced the presentation of preclinical results in preclinical leukemia models for its antimitotic agent, ENMD-1198, in combination with vincristine. The data were presented by EntreMed collaborator, Dr. Maria Kavallaris, at the American Society of Hematology Annual Meeting being held December 8-11, 2007 in Atlanta, Georgia.

(Photo: Newscom: http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO)

Data presented demonstrate that ENMD-1198, administered as a single agent, is effective in significantly delaying the growth of leukemia xenografts in vivo. Combination studies with ENMD-1198 and another microtubule targeting agent commonly used in the treatment of leukemias, vincristine, demonstrate synergistic effects on leukemia cells in vitro and tolerability of doses that prolonged survival in leukemia xenograft models.

ENMD-1198, a new chemical entity (NCE) derived from 2-methoxyestradiol (2ME2), was designed to decrease metabolism while retaining 2ME2's multiple mechanisms of action, including inducing apoptosis, disrupting microtubules, and inhibiting HIF-1alpha. In prior preclinical studies, ENMD-1198, an orally active antimitotic agent, leads to arrest of cell division and apoptosis in tumor cells. ENMD-1198 also exerts antiangiogenic activity that further contributes to its overall antitumor effects.

Mark R. Bray, Ph.D., EntreMed Vice Pre
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine news :

1. EntreMed Receives Deloitte Technology Fast 50 Award
2. EntreMed to Present at the Bio 2007 Investor Forum
3. EntreMed Presents Results for Panzem(R) NCD Phase 2 Ovarian Cancer Study
4. EntreMed to Present at the Rodman and Renshaw 9th Annual Healthcare Conference
5. EntreMed Reports Third Quarter 2007 Financial Results
6. Updated GOLD report presents new understandings in diagnosis, treatment and prevention of COPD
7. The Art Of Maternity(TM) at Destination Maternity(R) Presents A Sacred Passage Into Motherhood; the Art of Belly Masking to Belly Casting
8. Presentation Time Correction: Keryx Biopharmaceuticals Presents at 12:00pm, ET Tomorrow (Oct. 3) at William Blair & Company Small-Cap Growth Stock Conference
9. VNUS Medical Technologies Presents at William Blair Small-Cap Growth Stock Conference
10. NARSAD - Worlds Leading Mental Health Research Charity - Presents 19th Annual New York Mental Health Symposium, Oct. 19th & 20th
11. Retirement Living TV Presents Sex, Drugs and Rock N Roll

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...ission vehicles may reduce future disease burden, ...lthDay News) -- Encouraging city dwellers to walk ... greater public health benefits than increased use...found. , The study compared the projected healt...ort scenarios for London, England, and Delhi, Indi...
(Date:11/27/2009)...t Health™ announced today that Spectrum Heal...aCad Enterprise orthopedic templating solution and... (PRWEB) November 27, 2009 -- Voy...alth (Grand Rapids, Michigan) has licensed its Tra...nd its TraumaCad Extend workflow solution, to allo...
(Date:11/27/2009)... new interactive anatomy education apps from Modal...ealth sciences learning opportunities for iPhone a...C (Vocus) November 27, 2009 -- Modality, Inc. an...ion of Wolters Kluwer Health, today announced the ...n the App Store. Clemente’s Anatomy, Rohen&r...
(Date:11/26/2009)...ber of Americans living with diabetes will nearly ....1 million in 2034. Over the same period, spending...billion to $336 billion, even with no increase in ...e University of Chicago report in the December iss...h diabetes covered by Medicare will rise from 8.2 ...
(Date:11/26/2009)...n an emotional rollercoaster, study finds , ...t the fear factor meets the jubilant sports fan. ,...ally those who root for the winning team -- enjoy ...ted match and victory was in doubt, producing feel...this Thanksgiving weekend as you,re glued to the T...
Breaking Medicine News(10 mins):Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3
...the Sense About Science organization reveal that t... not necessary. The body // has the capacity to t...nces. Some of the substances that are ingested ar...flushing out of the toxins from our body. The turn...
..., General practitioner and founder president of th...t. Campbell is pioneer // in founding the nationa...ignorant about the health problems involved with o...eatened him they will take legal action against hi...
...t the federal government is not yet prepared to fa...t Bush allotted $3.8 billion // for bird flu dru...epared to face a pandemic of bird flu but the prep...in immediate threat of any bird flu virus as there...
...ose weight loss gimmicks, potions and wonder shake...ound knowledge and information. So the only soluti...g doesn’t mean starving yourself. Rather, it is ch...ep it off. The simple funda is more the inpu...
...de news recently due to its wide spreading nature ... put an end to its // spread across the country....he disease was reduced and area, which has been in... only three areas are infected with bird flu. They...
...d by Dr Judith Paice, director of the Cancer Pain ...cago // included 50 patients. They were suffering...rt therapy classes. The art therapy classes in...ey experienced decreased pain, depression, breathl...
Other Medicine News:Health News:Start the New year with news on intelligent weight loss!! 2Health News:Art therapy compliments cancer therapy. 2
(Date:11/25/2009)...v.25/PRNewswire/--BioTrendsResearchGroup,Inc.relea...t,thefirstinamulti-phasesyndicatedmarketresearchpr...lara,fromproductlaunchthroughthefirstsixmonthsofav...informationfrom75uniqueDermatologistsandqualitativ...nduseofStelara,obstaclestouse,typicalpatienttypes,...
(Date:11/25/2009)...Md.,Nov.25/PRNewswire-USNewswire/--RemediumTechnol...thatstopsseverebleeding,wonfirstprizeand$10,000int...rityChallenge2009,companyofficialsannouncetoday. ,...rld,Remedium,steampitchedtheirinventionattheGSCSec...ss. ,, Remedium( www.remediumtechnologies.com )...
(Date:11/25/2009)...,Nov.25/PRNewswire-Asia-FirstCall/--ChinaSkyOne,Me...daq: CSKI ),a,leadingfullyintegratedpharmaceutical...sinthePeople,sRepublicofChina("PRC"),today,announc...stitutefor,theControlofPharmaceuticalandBiological...s:itsDiagnosticKitforHumanProstateSpecific,Antigen...
Breaking Medicine Technology:Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3REPEAT 3A Project Runway Designer in New Orleans to Educate About Living with HIV and Combat Stigma Associated with the Disease through Living Positiv 57712 1REPEAT 3A Project Runway Designer in New Orleans to Educate About Living with HIV and Combat Stigma Associated with the Disease through Living Positiv 57712 2REPEAT 3A Project Runway Designer in New Orleans to Educate About Living with HIV and Combat Stigma Associated with the Disease through Living Positiv 57712 3U S Census Bureau Daily Feature for Sept 20 57708 1Strain on nanocrystals could yield colossal results 14156 1Strain on nanocrystals could yield colossal results 14156 2Strain on nanocrystals could yield colossal results 14156 3
...lls Inc. (BCI), a,biopharmaceutical company utiliz...p compounds that promote the growth of new neurons... diseases, announced today that it has,initiated a...didate,BCI-540, for the treatment of depression wi... expressed by our clinical,investigators who view ...
...Predictable, Extended Exposure with Sustained- ...O, April 17 Data from the first pivotal study of,...ional compound to treat,Restless Legs Syndrome (RL...toms of moderate-to-severe primary RLS compared to...ministered once-daily for 12 weeks., Data from th...
Other Medicine Technology:BrainCells Inc. Initiates Phase 2 Clinical Trial with BCI-540 for Depression with Anxiety 2Data Presented at the American Academy of Neurology Show XP13512/GSK1838262 Significantly Improved Symptoms of Moderate-to-Severe Primary Restless Legs Syndrome 2Data Presented at the American Academy of Neurology Show XP13512/GSK1838262 Significantly Improved Symptoms of Moderate-to-Severe Primary Restless Legs Syndrome 3Data Presented at the American Academy of Neurology Show XP13512/GSK1838262 Significantly Improved Symptoms of Moderate-to-Severe Primary Restless Legs Syndrome 4Data Presented at the American Academy of Neurology Show XP13512/GSK1838262 Significantly Improved Symptoms of Moderate-to-Severe Primary Restless Legs Syndrome 5Data Presented at the American Academy of Neurology Show XP13512/GSK1838262 Significantly Improved Symptoms of Moderate-to-Severe Primary Restless Legs Syndrome 6
ABX Micros IM Hematology Analyzers
Sequitor™ Steerable Guidewire
Rio™ Aspiration Catheter
Reference Lab Interface (RLI)©
Medicine Products: